Metraipolis › archive › dc_defaff922b87

Osimertinib retreatment for patients with advanced EGFR-mutated non-small cell lung cancer — Europe PMC PMID:41175446

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41175446
DOI
10.1016/j.ctarc.2025.101026
License (as archived)
solo-consultazione
Archived
2026-11-09T01:32:21.894Z
SHA-256 of the archived text
50a6cfd2ff2fafa30258d5ca25c7bf6312885e2e22db507f01140b87a891e301
Stable URL of this page
https://metraipolis.com/documento/dc_defaff922b87

How to cite

Osimertinib retreatment for patients with advanced EGFR-mutated non-small cell lung cancer — Europe PMC PMID:41175446 — Europe PMC (en), https://europepmc.org/article/MED/41175446 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_defaff922b87 (Metraipolis archive dc_defaff922b87, sha256 50a6cfd2ff2fafa30258d5ca25c7bf6312885e2e22db507f01140b87a891e301)
BibTeX
@misc{dcdefaff922b87,
  title = {Osimertinib retreatment for patients with advanced EGFR-mutated non-small cell lung cancer — Europe PMC PMID:41175446},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41175446},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_defaff922b87; sha256 50a6cfd2ff2fafa30258d5ca25c7bf6312885e2e22db507f01140b87a891e301},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41175446. Agents can read the archived copy with the MCP tool read_document.